|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 23, 2017 ) According to the report Liquid Biopsy market, published by Market Data Forecast, Global market is expected to increase at a CAGR of 24.3% in the forecast period of 2016-2021 and reach a value of USD 1.75 billion by 2021 from USD 590.2 million in 2016.
For full report refer to http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/
Free sample of the report is available at http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/request-sample
This technology of liquid biopsy has enormous diagnostic and treatment implications for oncology and it is believed to transform clinical practice. A liquid biopsy, may capture the entire heterogeneity of the disease. This methodology is advantageous over tissue biopsies as monitoring of tumour genomic can be done by taking serial samples.
Foremost drivers for the liquid biopsy market include. Liquid biopsies are adopted due to the factors such as tolerability and patient convenience. Tissue biopsies cannot be done for few non-small cell lung cancers and liquid biopsy procedures are replacing tissue diagnosis procedures in such cases. Liquid biopsy research process involves a large amount of money and frequent clinical trials which is acting as a restraint for the market growth.
The liquid biopsy market is mainly segmented by types of cancer into Lung Cancer, Pancreatic Cancer, Leukemia and Other Visceral Cancers. By Diagnostic approach they can be classified as Circulating Tumour cells (CTC), Circulating Tumour DNA (ctDNA), RNA in exosomes and Extra-Cellular Vesicles. Based on end users, the market is segmented into reference laboratories, hospital/physician laboratories, academic and research centers, and other end users. The market is bifurcate into blood, urine, plasma, saliva and Cerebrospinal fluid based upon sample type. CTCs (Circulating Tumour cells), the first such entities on the liquid biopsy scene, have accounted for a large share in the market. Cancer institute is the largest end user segment in terms of revenues and is expected to create substantial opportunity in global liquid biopsy market over the forecast period.
Enquire more about the report http://www.marketdataforecast.com/market-reports/global-liquid-biopsy-market-950/inquire
The Liquid Biopsy Market is segmented as follows:
By Cancer Type:
Lung Cancer
Pancreatic Cancer
Leukaemia
Other Visceral Cancers
By Sample Type:
Blood
Urine
Plasma
Saliva
Cerebrospinal
By Diagnostic Approach:
Circulating Tumour cells (CTC)
Circulating Tumour DNA (ctDNA)
RNA in exosomes
Extra-Cellular Vesicles
By End Users:
Reference Laboratories
Hospital/Physician Laboratories
Academic and Research Centres
Other End Users
Based on Geography
North America Liquid biopsy market
Europe Liquid biopsy market
Asia-Pacific Liquid biopsy market
Latin America Liquid biopsy market
Middle East and Africa Liquid biopsy market
The key players dominating the liquid biopsy market are Janssen Diagnostics, Qiagen, Rarecells SAS, Silicon Biosystems, SRI International, Myriad Genetics, Natera, Personal Genome Diagnostics, Sysmex Inostics, Trovagene, Exosome Diagnostics, Exosome Sciences, and HansaBiomed OU.
Buy now https://www.marketdataforecast.com/cart/buy-now/global-liquid-biopsy-market-950
The Liquid Biopsy Market study offers the following deliverables:
Global, Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development.
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout related reports in the Diagnostic Category:
Acute Ischemic Stroke Diagnosis and Treatment Market: http://www.marketdataforecast.com/market-reports/global-acute-ischemic-stroke-diagnosis-market-265/
Autoimmune Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-auto-immune-diagnostics-market-1190/
Blood Testing Market: http://www.marketdataforecast.com/market-reports/global-blood-testing-market-1405/
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
